Antivenom drugs are used to treat venomous bites and stings, usually preferable in high-toxicity cases. Antivenin, venom antiserum, and antivenom immunoglobulin are the different other names of antivenom drugs. These medications can potentially reverse the effects of snake bites, and generally, an adequate therapeutic dose is injected. Additionally, these medications also help in kidney dialysis, artificial respiration, prosthesis as well as rehabilitation services.
The global market for Antivenom Drugs is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Antivenom Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Antivenom Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Antivenom Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Antivenom Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Antivenom Drugs players cover Bioclone Institute, Pfizer Inc, F. Hoffmann-La Roche Ltd, Merck KGaA and Rare Disease Therapeutics, Inc, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This latest report provides a deep insight into the global Antivenom Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Antivenom Drugs market, with both quantitative and qualitative data, to help readers understand how the Antivenom Drugs market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
The study segments the Antivenom Drugs market and forecasts the market size by Type (Antineurotoxin, Anticirculatory Toxin and Antimixing Toxin), by Application (Hospital, Clinical Laboratory, Field Rescue Station and Other), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Segmentation by application
Field Rescue Station
Segmentation by region
Middle East & Africa
Major companies covered
F. Hoffmann-La Roche Ltd
Rare Disease Therapeutics, Inc
VINS Bioproducts Ltd
BTG International Inc
Bharat Serums and Vaccines Limited
B. Braun SE
Boston Scientific Corporation
Chapter 1: Scope of Antivenom Drugs, Research Methodology, etc.
Chapter 2: Executive Summary, global Antivenom Drugs market size (sales and revenue) and CAGR, Antivenom Drugs market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Antivenom Drugs sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Antivenom Drugs sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Antivenom Drugs market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Bioclone Institute, Pfizer Inc, F. Hoffmann-La Roche Ltd, Merck KGaA, Rare Disease Therapeutics, Inc, VINS Bioproducts Ltd, BTG International Inc, Incepta Pharma and Bharat Serums and Vaccines Limited, etc.
Chapter 14: Research Findings and Conclusion